Novartis CEO says it won't join weight-loss drug frenzy
The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…
pharmaceutical products
Pfizer's drug for cancer cachexia shows positive results in mid-phase trials
PfizerPfizer's experimental drug for a common, potentially fatal disease that causes cancer patients to lose appetite and weight showed positive…
Florida advises against the use of mRNA vaccines against Covid in older adults
As the Covid wave continues in Florida, Gov. Ron DeSantis' administration is again advising against mRNA vaccines — this time…
Noom to offer GLP-1 drug through new weight loss program
Digital health company Noom announced Thursday that it will offer a compounded GLP-1 drug as part of a new weight-loss…
$1 billion in cost cuts and 10 planned product launches
Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images…
Eli Lilly to increase production of weight loss, diabetes and Alzheimer's drugs
A sign with the company logo is displayed outside Eli Lilly headquarters in Indianapolis, Indiana, March 17, 2024. Scott Olson…
AstraZeneca shares fall 5% on disappointing lung cancer drug trial
AstraZeneca Shares fell more than 5% on Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical…
We're making nearly 300% gains on a rising pharmaceutical stock
Shortly after the opening bell, we will sell 10 shares of Eli Lilly at approximately $958 each. Following Monday's trade,…
FDA authorizes Novavax's Covid-19 vaccine targeting JN.1
This illustration taken on January 16, 2022, shows a vial labeled “Novavax V COVID-19 Vaccine.” Dado Ruvic | Reuters The…
Eli Lilly launches new, cheaper form of weight-loss drug
An injection pen for Eli Lilly's weight-loss drug Zepbound is displayed in New York City on December 11, 2023. Brendan…